🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
4,720 results for “eu”
MedicineActive substanceLicence holderStatus
Lacosamide Adroiq 10 mg/ml solution for infusion
EU/1/23/1732/001
Lacosamide Extrovis EU Kft.
Lacosamide Fresenius Kabi 10 mg/ml solution for infusion
PA2059/078/001
Lacosamide Fresenius Kabi Deutschland GmbH Not marketed
Lacosamide UCB 10 mg/ml Syrup
EU/1/19/1383/003
Lacosamide UCB Pharma S.A.
Lacosamide UCB 100 mg Film-coated tablet
EU/1/19/1383/010-015
Lacosamide UCB Pharma S.A.
Lacosamide UCB 150 mg Film-coated tablet
EU/1/19/1383/016-021
Lacosamide UCB Pharma S.A.
Lacosamide UCB 200 mg Film-coated tablet
EU/1/19/1383/022-027
Lacosamide UCB Pharma S.A.
Lacosamide UCB 50 mg Film-coated tablet
EU/1/19/1383/004-009
Lacosamide UCB Pharma S.A.
Lamictal 100 mg Tablets
PPA23080/014/002
Lamotrigine Merit Pharmaceuticals Limited
Lamictal 25 mg tablets
PPA23080/014/001
Lamotrigine Merit Pharmaceuticals Limited
Lamivudine Teva 100 mg film-coated tablets
EU/1/09/566/1-5
Lamivudine Teva Pharma B.V.
Lamivudine Teva Pharma B.V. 150 mg film-coated tablets
EU/1/09/596/1-7
Lamivudine Teva Pharma B.V.
Lamivudine Teva Pharma B.V. 300 mg film-coated tablets
EU/1/09/596/8-14
Lamivudine Teva Pharma B.V.
Lamzede 10 mg powder for solution for infusion
EU/1/17/1258/001-003
Velmanase alfa Chiesi Farmaceutici S.p.A.
Lanreotide SUN 120 mg solution for injection in a pre-filled syringe
PA2050/009/003
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lanreotide SUN 60 mg solution for injection in a pre-filled syringe
PA2050/009/001
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lanreotide SUN 90 mg solution for injection in a pre-filled syringe
PA2050/009/002
Lanreotide Sun Pharmaceutical Industries Europe B.V. Not marketed
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/005
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/006
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a cartridge
EU/1/00/134/007
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/001
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/002
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/003
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus 100 units/ml solution for injection in a vial
EU/1/00/134/004
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lantus SoloStar 100 units/ml solution for injection in a pre-filled pen
EU/1/00/134/030-037
Insulin glargine Sanofi-Aventis Deutschland GmbH
Lartruvo
EU/1/16/1143/001
Olaratumab Eli Lilly Nederland B.V.
Latuda 18.5 mg film-coated tablets
EU/1/14/913/001-007
Lurasidone hydrochloride Aziende Chimiche Riunite Angelini Francesco
Latuda 37 mg film-coated tablets
EU/1/14/913/008-014
Lurasidone hydrochloride Aziende Chimiche Riunite Angelini Francesco
Latuda 74 mg film-coated tablets
EU/1/14/913/015-021
Lurasidone hydrochloride Aziende Chimiche Riunite Angelini Francesco
LAVENTAIR ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed
EU/1/14/899/001-003
Umeclidinium bromide, Vilanterol trifenatate GlaxoSmithKline Trading Services Limited
Lazcluze 240 mg film-coated tablets
EU/1/24/1886/004-006
Lazertinib Janssen-Cilag International NV
Lazcluze 80 mg film-coated tablets
EU/1/24/1886/001-003
Lazertinib Janssen-Cilag International NV
Lecigon 20 mg/ml + 5 mg/ml + 20 mg/ml intestinal gel
PA23144/001/001
Levodopa, Carbidopa monohydrate, Entacapone Lobsor Pharmaceuticals AB Marketed
Ledaga 160 micrograms/g gel
EU/1/16/1171/001
Chlormethine hydrochloride Helsinn Birex Pharmaceuticals Limited
Leflunomide medac 10 mg film-coated tablets
EU/1/10/637/001-004
Leflunomide medac Gesellschaft für klinische Spezialpräparate mbH
Leflunomide medac 15 mg film-coated tablets
EU/1/10/637/010-012
Leflunomide medac Gesellschaft für klinische Spezialpräparate mbH
Leflunomide medac 20 mg film-coated tablets
EU/1/10/637/005-009
Leflunomide medac Gesellschaft für klinische Spezialpräparate mbH
Leflunomide ratiopharm
EU/1/10/654/003-004
Ratiopharm GmbH
Leflunomide Zentiva 10 mg film-coated tablets
EU/1/09/604/1-4
Leflunomide Zentiva k.s.
Leflunomide Zentiva 100 mg film-coated tablets
EU/1/09/604/10
Leflunomide Zentiva k.s.
Leflunomide Zentiva 20 mg film-coated tablets
EU/1/09/604/5-9
Leflunomide Zentiva k.s.
Lemsip Max Sinus & Flu Hot Lemon Powder for Oral Solution
PA0979/020/001
Paracetamol, PSEUDOEPHEDRINE HYDROCHLORIDE Reckitt Benckiser Ireland Ltd Not marketed
LEMTRADA 12 mg concentrate for solution for infusion
EU/1/13/869/001
Alemtuzumab Sanofi Belgium
Lenalidomide Accord 10 mg hard capsules
EU/1/18/1316/006-007
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 15 mg hard capsules
EU/1/18/1316/008-009
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 2.5 mg hard capsules
EU/1/18/1316/001-002
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 20 mg hard capsules
EU/1/18/1316/010
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 25 mg hard capsules
EU/1/18/1316/011
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 5 mg hard capsules
EU/1/18/1316/003-004
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Accord 7.5 mg hard capsules
EU/1/18/1316/005
Lenalidomide Accord Healthcare S.L.U.
Lenalidomide Krka 10 mg hard capsules
EU/1/20/1519/007-008
Lenalidomide hydrochloride hydrate, Lenalidomide KRKA, d.d., Novo mesto
39 40 41 42 43 44 45
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.